Concepedia

CYP2D6 genotype in relation to hot flashes as tamoxifen side effect in a Dutch cohort of the tamoxifen exemestane adjuvant multinational (TEAM) trial

Vincent O. Dezentjé, Hans Gelderblom, Ron H. N. van Schaik, J. M. Vletter-Bogaartz, Tahar van der Straaten, Judith A.M. Wessels, Elma Meershoek‐Klein Kranenbarg, Els M.J.J. Berns, Caroline Seynaeve, Hein Putter,

Breast Cancer Research and Treatment · 2013 · 18 citations · 22 references

DOI

Concepts

References

22

Pharmacogenetics of Tamoxifen Biotransformation Is Associated With Clinical Outcomes of Efficacy and Hot Flashes

Matthew P. Goetz, James M. Rae, Vera J. Suman et al. · Journal of Clinical Oncology · 2005 · 786 citations · Full text

, , +16

Association Between CYP2D6 Polymorphisms and Outcomes Among Women With Early Stage Breast Cancer Treated With Tamoxifen

Werner Schroth · JAMA · 2009 · 529 citations · Full text

, , +17

Adjuvant tamoxifen and exemestane in early breast cancer (TEAM): a randomised phase 3 trial

Cornelis JH van de Velde, Daniel Rea, Caroline Seynaeve et al. · The Lancet · 2011 · 377 citations

, , +15

CYP2D6 Genotype and Tamoxifen Response in Postmenopausal Women with Endocrine-Responsive Breast Cancer: The Breast International Group 1-98 Trial

Meredith M. Regan, Brian Leyland‐Jones, Mark Bouzyk et al. · JNCI Journal of the National Cancer Institute · 2012 · 338 citations · Full text

, , +16

Tamoxifen Metabolite Concentrations, CYP2D6 Genotype, and Breast Cancer Outcomes

Lisa Madlensky, Loki Natarajan, Simone Tchu et al. · Clinical Pharmacology & Therapeutics · 2011 · 329 citations · Full text

, , +16